TY - JOUR
AU - Nimmo, Ailish
AU - Risdale, Saira
PY - 2021
DA - June
TI - Adapted treatment of ANCA-associated vasculitis during the COVID-19 pandemic
JO - Rheumatology Advances in Practice
VL - 5
IS - 2
DO - https://doi.org/10.1093/rap/rkab041
AB - The ANCA-associated vasculitides (AAV) are multisystem diseases presenting with wide-ranging symptoms and, frequently, a long prodrome of malaise before diagnosis. We observed that patterns of presentation with AAV altered during the coronavirus disease 2019 (COVID-19) pandemic, and consideration of the infection risk led us to change our treatment of the disease. We report the outcomes of patients with AAV with kidney involvement at a tertiary renal unit in the UK, covering a population of 1.6 million. We observed only onede novopresentation of AAV during the first lockdown in March–June 2020, followed by 11 cases in the latter part of the year (nine MPO-ANCA and two PR3-ANCA), including five during the second lockdown from November to December 2020.
PB - Oxford University Press
UR - https://www.research.ed.ac.uk/en/publications/8b35c0c6-7437-4d0b-911a-6a7fe6e62570
KW - Coronavirus (COVID-19)
ER